More HeraMED Ltd news
HeraMED LtdASX: HMD

Clinical & Functional Validation of HeraBEAT Achieved at JHC

Oct 7, 2020 at 9:41 PM EDT · Issued by HeraMED Ltd

Filed with ASX · Oct 7, 2020 at 9:41 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/clinical-and-functional-validation-of-herabeat-achieved-at-jhc

HeraMED Ltd on 6ix

Earlier from HeraMED

  • Partnership with Leading Virtual Care Platform eCare21 in USSep 15, 2020
  • Updated Quarterly Activities ReportAug 3, 2020
  • HeraMED Extends its Collaboration with Mayo ClinicJul 20, 2020
  • Pause In TradingJul 16, 2020
  • Results of Share Purchase Plan OfferJul 13, 2020

Later from HeraMED

  • Partnership with eCare21 & functional integration completedNov 8, 2020
  • Partnership to Launch HeraCARE & HeraBEAT with TeleperinatalDec 14, 2020
  • Mayo Clinic approves Clinical Study of HeraBEATDec 15, 2020
  • Completion of AUD 2.3M PlacementFeb 3, 2021
  • Israels Largest Healthcare Provider Begins Pilot StudyFeb 7, 2021
All HeraMED news releases↗

Follow HeraMED into a list and get an email when it puts out news.

Follow HeraMED
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer